New WHO Public Inspection Reports (WHOPIRs) published
IVD
IS
M
First dihydroartemisinin/piperaquine 30mg/240mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First pretomanid prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Remdesivir removed from the PQT Invitations for Expression of Interest (EOIs) (FPPs and APIs)
M
Remdesivir removed from the PQT Invitations for Expression of Interest (EOIs) (FPPs and APIs).
See link for recent World Health Organization (WHO) recommendations:
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
M
New Invitation for Expression of Interest (EOI) for Active Pharmaceutical Ingredients (APIs) published
New Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
M
New Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
New Invitation for Expression of Interest (EOI) for HIV infection and related diseases medicines published
M
New Invitation for Expression of Interest (EOI) for HIV/AIDS medicines published
Draft TSS 7 - Annex 1: Qualification of usability for self-testing with rapid diagnostic tests to detect hepatitis C antibody - available for public comment
IVD
The DRAFT TSS 7 - Annex 1 Qualification of usability for self-testing with rapid diagnostic tests to detect hepatitis C antibody is now avaiable for public comments.